Alcohol consumption is directly associated with circulating oxidized low-density lipoprotein

Free Radical Biology and Medicine

Volumn 40, Issue 8, 2006, Pages 1474-1481

  Schroder, Helmut ^a   Marrugat, Jaume ^a   Fíto, Montserrat ^a   Weinbrenner, Tanja ^b   Covas, Maria Isabel ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Alcohol; Alcoholic beverages; Cardiovascular risk factors; Free radical; Nutrition; Oxidized LDL

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACADEMIC ACHIEVEMENT; ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BEER; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIVARIATE ANALYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SPAIN; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WINE;

ADULT; AGED; ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; ETHANOL; FEMALE; HUMANS; LIFE STYLE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NUTRITION PHYSIOLOGY; QUESTIONNAIRES; RISK FACTORS;

EID: 33646038930     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.12.014     Document Type: Article

References (51)

1. Rehm J., Room R., Graham K., Monteiro M., Gmel G., and Sempos C.T. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 98 (2003) 1209-1228
2. Rimm E.B., Klatsky A., Grobbee D., and Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. Br. Med. J. 312 (1996) 731-736
3. McDonough K.H. Antioxidant nutrients and alcohol. Toxicology 189 (2003) 89-97
4. Wu D., and Cederbaum A.I. Alcohol, oxidative stress, and free radical damage. Alcohol Res. Health 27 (2003) 277-284
5. Kono H., Rusyn I., Yin M., Gabele E., Yamashina S., Dikalova A., Kadiiska M.B., Connor H.D., Mason R.P., Segal B.H., Bradford B.U., Holland S.M., and Thurman R.G. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest. 106 (2000) 867-872
6. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793-795
7. Salonen J.T., Yla-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssonen K., Palinski W., and Witztum J.L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339 (1992) 883-887
8. Berliner J.A., and Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20 (1996) 707-727
9. Di Bari M., Zacchei S., Kritchevsky S.B., Anichini M., Cesaretti S., Chiarlone M., Masotti G., and Marchionni N. Anti-oxidized LDL antibodies and wine consumption: a population-based epidemiological study in Dicomano, Italy. Ann. Epidemiol. 13 (2003) 189-195
10. Salonen J.T., Yla-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssonen K., Palinski W., and Witztum J.L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339 (1992) 883-887
11. Hulthe J., Wiklund O., Hurt-Camejo E., and Bondjers G. Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2). Arterioscler. Thromb. Vasc. Biol. 21 (2001) 269-274
12. Kerry N.L., and Abbey M. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis 135 (1997) 93-102
13. Chopra M., Fitzsimons P.E., Strain J.J., Thurnham D.I., and Howard A.N. Nonalcoholic red wine extract and quercetin inhibit LDL oxidation without affecting plasma antioxidant vitamin and carotenoid concentrations. Clin. Chem. 46 (2000) 1162-1170
14. Schroder H., Covas M.I., Marrugat J., Vila J., Pena A., Alcantara M., and Masia R. Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin. Nutr. 20 (2001) 429-437
15. Elosua R., Garcia M., Aguilar A., Molina L., Covas M.I., and Marrugat J. Validation of the Minnesota leisure time physical activity questionnaire in Spanish women. Investigators of the MARATDON Group. Med. Sci. Sports Exerc. 32 (2000) 1431-1437
16. Elosua R., Marrugat J., Molina L., Pons S., and Pujol E. Validation of the Minnesota leisure time physical activity questionnaire in Spanish men. The MARATHOM Investigators. Am. J. Epidemiol. 139 (1994) 1197-1209
17. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., O'Brien W.L., Bassett Jr. D.R., Schmitz K.H., Emplaincourt P.O., Jacobs Jr. D.R., and Leon A.S. Compendium of physical activities: an update of activity codes and MET intensities. Med. Sci. Sports Exerc. 32 (2000) S498-S504
18. Cejas P., Casado E., Belda-Iniesta C., Castro J.D., Espinosa E., Redondo A., Sereno M., Garcia-Cabezas M.A., Vara J.A., Dominguez-Caceres A., Perona R., and Gonzalez-Baron M. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 15 (2004) 707-719
19. Zhu X., Raina A.K., Lee H.G., Casadesus G., Smith M.A., and Perry G. Oxidative stress signalling in Alzheimer's disease. Brain Res. 1000 (2004) 32-39
20. Yorek M.A. The role of oxidative stress in diabetic vascular and neural disease. Free Radic. Res. 37 (2003) 471-480
21. Diaz M.N., Frei B., Vita J.A., and Keaney Jr. J.F. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337 (1997) 408-416
22. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., Komatsu R., Matsuo T., Itabe H., Takano T., Tsukamoto Y., Yoshiyama M., Takeuchi K., Yoshikawa J., and Becker A.E. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
23. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., and Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98 (1998) 1487-1494
24. Toshima S., Hasegawa A., Kurabayashi M., Itabe H., Takano T., Sugano J., Shimamura K., Kimura J., Michishita I., Suzuki T., and Nagai R. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc. Biol. 20 (2000) 2243-2247
25. Weinbrenner T., Cladellas M., Isabel C.M., Fito M., Tomas M., Senti M., Bruguera J., and Marrugat J. High oxidative stress in patients with stable coronary heart disease. Atherosclerosis 168 (2003) 99-106
26. Shoji T., Nishizawa Y., Fukumoto M., Shimamura K., Kimura J., Kanda H., Emoto M., Kawagishi T., and Morii H. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148 (2000) 171-177
27. Zima T., Fialova L., Mestek O., Janebova M., Crkovska J., Malbohan I., Stipek S., Mikulikova L., and Popov P. Oxidative stress, metabolism of ethanol and alcohol-related diseases. J. Biomed Sci. 8 (2001) 59-70
28. Alho H., Sillanaukee P., Kalela A., Jaakkola O., Laine S., and Nikkari S.T. Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein. Alcohol 39 (2004) 312-315
29. Young I.S., and Woodside J.V. Antioxidants in health and disease. J. Clin. Pathol. 54 (2001) 176-186
30. Cooper C.E., Vollaard N.B., Choueiri T., and Wilson M.T. Exercise, free radicals and oxidative stress. Biochem. Soc. Trans. 30 (2002) 280-285
31. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43 (2004) 1731-1737
32. Sigurdardottir V., Fagerberg B., and Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J. Intern. Med. 252 (2002) 440-447
33. Frostegard J., Wu R., Lemne C., Thulin T., Witztum J.L., and de Faire U. Circulating oxidized low-density lipoprotein is increased in hypertension. Clin. Sci. (Lond) 105 (2003) 615-620
34. Pryor W.A., and Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N. Y. Acad. Sci. 686 (1993) 12-27
35. Reilly M., Delanty N., Lawson J.A., and FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94 (1996) 19-25
36. Miller E.R.I., Appel L.J., Jiang L., and Risby T.H. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 96 (1997) 1097-1101
37. Yamaguchi Y., Haginaka J., Morimoto S., Fujioka Y., and Kunitomo M. Facilitated nitration and oxidation of LDL in cigarette smokers. Eur. J. Clin. Invest. 35 (2005) 186-193
38. Yamaguchi Y., Kagota S., Haginaka J., and Kunitomo M. Participation of peroxynitrite in oxidative modification of LDL by aqueous extracts of cigarette smoke. FEBS Lett. 512 (2002) 218-222
39. Hasegawa T., Kikuyama M., Sakurai K., Kambayashi Y., Adachi M., Saniabadi A.R., Kuwano H., and Nakano M. Mechanism of superoxide anion production by hepatic sinusoidal endothelial cells and Kupffer cells during short-term ethanol perfusion in the rat. Liver 22 (2002) 321-329
40. Morel D.W., DiCorleto P.E., and Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4 (1984) 357-364
41. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320 (1989) 915-924
42. Bechara R.I., Brown L.A., Eaton D.C., Roman J., and Guidot D.M. Chronic ethanol ingestion increases expression of the angiotensin II type 2 (AT2) receptor and enhances tumor necrosis factor-alpha- and angiotensin II-induced cytotoxicity via AT2 signaling in rat alveolar epithelial cells. Alcohol Clin. Exp. Res. 27 (2003) 1006-1014
43. Belleville J. The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition 18 (2002) 173-177
44. Abou-Agag L.H., Khoo N.K., Binsack R., White C.R., Darley-Usmar V., Grenett H.E., Booyse F.M., Digerness S.B., Zhou F., and Parks D.A. Evidence of cardiovascular protection by moderate alcohol: role of nitric oxide. Free Radic. Biol. Med. 39 (2005) 540-548
45. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., Willett W., and Hennekens C.H. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N. Engl. J. Med. 329 (1993) 1829-1834
46. Parker D.R., McPhillips J.B., Derby C.A., Gans K.M., Lasater T.M., and Carleton R.A. High-density-lipoprotein cholesterol and types of alcoholic beverages consumed among men and women. Am. J. Public Health 86 (1996) 1022-1027
47. Wollin S.D., and Jones P.J. Alcohol, red wine and cardiovascular disease. J. Nutr. 131 (2001) 1401-1404
48. Zern T.L., and Fernandez M.L. Cardioprotective effects of dietary polyphenols. J. Nutr. 135 (2005) 2291-2294
49. Barefoot J.C., Gronbaek M., Feaganes J.R., McPherson R.S., Williams R.B., and Siegler I.C. Alcoholic beverage preference, diet, and health habits in the UNC Alumni Heart Study. Am. J. Clin. Nutr. 76 (2002) 466-472
50. van Tol A., and Hendriks H.F. Moderate alcohol consumption: effects on lipids and cardiovascular disease risk. Curr. Opin. Lipidol. 12 (2001) 19-23
51. Hannuksela M.L., Ramet M.E., Nissinen A.E., Liisanantti M.K., and Savolainen M.J. Effects of ethanol on lipids and atherosclerosis. Pathophysiology 10 (2004) 93-103